| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.07▲ | 7.15▼ | 7.12▼ | 7.04▲ | 5.88▲ |
| MA10 | 7.06▲ | 7.09▼ | 7.05▲ | 6.37▲ | 5.89▲ |
| MA20 | 7.10▼ | 7.03▲ | 7.07▲ | 5.84▲ | 5.47▲ |
| MA50 | 7.11▼ | 7.06▲ | 6.67▲ | 5.98▲ | 4.26▲ |
| MA100 | 7.04▲ | 6.59▲ | 5.98▲ | 5.29▲ | 3.69▲ |
| MA200 | 7.06▲ | 5.94▲ | 5.68▲ | 4.27▲ | 3.29▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.006▲ | -0.027▼ | 0.210▲ | 0.041▲ |
| RSI | 47.712▼ | 52.645▲ | 56.237▲ | 68.214▲ | 63.569▲ |
| STOCH | 61.668 | 69.169 | 53.623 | 92.867▲ | 43.308 |
| WILL %R | -15.385▲ | -51.685 | -51.111 | -12.157▲ | -19.676▲ |
| CCI | 126.841▲ | 14.755 | 44.417 | 103.231▲ | 122.268▲ |
|
Thursday, January 22, 2026 05:10 AM
The poster presentation will include updated safety and efficacy data from approximately 25 six-month evaluable BCG-Unresponsive NMIBC patients in the ongoing Phase 2 ADVANCED-2 trial. ADVANCED-2 ...
|
|
Sunday, January 04, 2026 03:59 PM
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
|
|
Saturday, December 20, 2025 04:00 PM
Fintel reports that on January 7, 2026, Piper Sandler initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a Overweight recommendation. As of December 21, 2025, the average one-year price ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 6.935 | 7.32 | 6.875 | 7.09 | 990,698 |
| 29/01/26 | 7.13 | 7.15 | 6.85 | 7.00 | 1,036,774 |
| 28/01/26 | 7.23 | 7.418 | 6.97 | 7.17 | 1,655,221 |
| 27/01/26 | 6.60 | 7.35 | 6.55 | 7.27 | 1,838,734 |
| 26/01/26 | 6.10 | 6.70 | 6.00 | 6.67 | 1,347,346 |
| 23/01/26 | 5.92 | 6.20 | 5.86 | 6.19 | 931,444 |
| 22/01/26 | 5.78 | 6.15 | 5.78 | 5.91 | 556,408 |
| 21/01/26 | 5.59 | 6.13 | 5.5601 | 5.77 | 1,636,083 |
| 20/01/26 | 4.89 | 5.615 | 4.871 | 5.60 | 1,088,124 |
| 16/01/26 | 5.05 | 5.11 | 4.72 | 5.01 | 1,172,347 |
|
|
||||
|
|
||||
|
|